NCT04665063 2020-12-29
A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Unknown
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Senlang Biotechnology Inc., Ltd.
Hebei Senlang Biotechnology Inc., Ltd.
Polyphor Ltd.